EDGAR Filing Documents for 0001193125-14-243923

Form 8-K - Current report:

SEC Accession No. 0001193125-14-243923

Filing Date

2014-06-20

Accepted

2014-06-20 16:30:53

Documents

Period of Report

2014-06-19

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d743971d8k.htm	8-K	48614
2	EX-10.1	d743971dex101.htm	EX-10.1	97914
3	EX-10.2	d743971dex102.htm	EX-10.2	21561
4	EX-10.3	d743971dex103.htm	EX-10.3	31717
5	EX-10.4	d743971dex104.htm	EX-10.4	32267
6	EX-10.5	d743971dex105.htm	EX-10.5	33170
7	EX-10.6	d743971dex106.htm	EX-10.6	22240
	Complete submission text file	0001193125-14-243923.txt		288999

Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130

Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866

Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)